Overview
A dual-compound research blend pairing Retatrutide, a GLP-1/GIP/glucagon triple agonist, with Cagrilintide, a long-acting amylin analogue, for studies of combined receptor pathways.
Specifications
- Contents: 10mg Retatrutide + 10mg Cagrilintide per vial
- Form: Lyophilized powder, sealed vial
- Purity: Third-party tested; see the batch Certificate of Analysis (COA)
- Storage: Store sealed, protected from light; refrigerate or freeze for long-term storage
Quality & Testing
Every batch ships with lot traceability. Certificates of Analysis are available on request or via the COA history for this product.
For Research Use Only. Not for human or veterinary use. Not approved by the FDA and not intended to diagnose, treat, cure, or prevent any disease. Sold only to qualified researchers for in-vitro and laboratory study.
Reviews
There are no reviews yet.